WHO / National Academies — Voluntary Medical Male Circumcision as an HIV-prevention intervention

What the study found

This WHO/National Academies consensus report reviewed three randomized controlled trials of voluntary medical male circumcision (VMMC) in high-prevalence settings. Across those trials, circumcision was linked to a substantially lower rate of heterosexually acquired HIV among men, and the report issued a strong recommendation — graded as high-quality evidence — that VMMC continue to be offered as an additional HIV-prevention option. ^[1]

an estimated 60% lower incidence of heterosexually acquired HIV infection in circumcised men

^[1]

Why it matters here

In manosphere debates, male circumcision is sometimes equated with female genital mutilation (FGM). This report is relevant to that comparison because it documents a measured health benefit for medical male circumcision — a reduced risk of HIV acquisition — whereas health bodies recognise FGM as having no medical benefit. It does not settle the separate ethical questions about consent and circumcision of minors, which fall outside the trials it reviews. It is cited on is male circumcision genital mutilation? as evidence on the documented health effects of medical male circumcision.